Skip to main content
Recall Canary
Metoprolol Succinate Extended-Release Tablets 25 mg
← Back to all recalls
DRUG RECALLMODERATE

Metoprolol Succinate Extended-Release Tablets 25 mg

Ascend Laboratories is recalling 25 mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution testing.

What to do

Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking this medication without consulting your doctor.

Posted
Updated
Recall No.
D-0547-2026
Agency
Firm
Ascend Laboratories, LLC
Recall ID
98821
Status
ONGOING

Why it was recalled

Failed Dissolution Specifications

How to identify it

UPC 25140859

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Where it was sold

Distributed in US.

Other recent recalls from Ascend Laboratories, LLC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-05-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification